SHR-1916: A Novel PEGylated Interleukin-2 Analogue with Altered Cellular Selectivity and Improved Pharmacokinetic Profiles for Cancer Immunotherapy. [PDF]
Drug Des Devel TherKong X, Lin Y, Ouyang C, Chen H, Gao X.
europepmc +1 more source
Interleukin-2 receptor signaling acts as a checkpoint that influences the distribution of regulatory T cell subsets. [PDF]
iScienceShouse AN, Villarino AV, Malek TR.
europepmc +1 more source
Serum Soluble Interleukin-2 Receptor as a Potential Marker for Assessing Disease Activity in the TAFRO Subtype of Idiopathic Multicentric Castleman Disease. [PDF]
Intern MedOzaki T +8 more
europepmc +1 more source
The Diagnostic Value of Interleukin-2 and Interferon-γ Induced by Fusion Protein (ESAT-6/CFP-10/Rv1985c) for Active Mycobacterium tuberculosis Infection. [PDF]
J Clin Lab AnalZhao Z +7 more
europepmc +1 more source
Low-dose interleukin 2 therapy halts the progression of post-streptococcal autoimmune complications in a rat model of rheumatic heart disease. [PDF]
mBioRafeek RAM +4 more
europepmc +1 more source
Inactivation of human interleukin-2 (IL-2) by alpha 2-macroglobulin-trypsin complexes.
, 1986 Wolfgang Borth, M. Teodorescu
openalex +1 more source
Related searches:
SummaryDiscovered in 1976, the lymphokine interleukin-2, intensively studied during the last years, plays a major role in the regulation of the immune function. The authors reviewing its principal properties, anticipate forthcoming prospects of considerable implications in therapy.Acta Clin. Bclg. 42, 4: 255–68.
M, Hiden, P, Nève
openaire +2 more sources